Tuesday - April 23, 2024
MD Anderson and TriSalus Life Sciences Announce Strategic Research Collaboration to Evaluate Treatment of Solid Tumors
April 09, 2021
HOUSTON, Texas, April 9 (TNSPar) -- The University of Texas's MD Anderson Cancer Center issued the following news release on April 8, 2021:

The University of Texas MD Anderson Cancer Center and TriSalus Life Sciences today announced a strategic research collaboration to evaluate the treatment of tumors of the pancreas and liver by integrating interventional delivery of SD-101, an investigational toll-like receptor 9 (TLR9) agonist, in combination with checkpoint inhibition immunothe . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products